PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Service de Médecine Vasculaire et Thérapeutique, CHU de St-Etienne, Saint-Etienne, France; INSERM, UMR1059, Equipe Dysfonction Vasculaire et Hémostase, Université Jean-Monnet, F-42055 Saint-Etienne, France; INSERM, CIC-1408, CHU Saint-Etienne, F-42055 Saint-Etienne, France; F-CRIN INNOVTE network, Saint-Etienne, France. Electronic address: laurent.bertoletti@gmail.com.\', \'Brigham and Women\'s Hospital, Cardiovascular Medicine Division, Boston, United States; Yale University School of Medicine, Center for Outcomes Research and Evaluation (CORE), New Haven, United States; Cardiovascular Research Foundation, New York, United States.\', \'Université de Lorraine, Inserm UMR_S 1116 DCAC, France; CHRU-Nancy, Vascular Medicine Division, Nancy Academic Hospital, F-54000 Nancy, France.\', \'Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.\', \'Service de Médecine Vasculaire et Thérapeutique, CHU de St-Etienne, Saint-Etienne, France; INSERM, UMR1059, Equipe Dysfonction Vasculaire et Hémostase, Université Jean-Monnet, F-42055 Saint-Etienne, France; INSERM, CIC-1408, CHU Saint-Etienne, F-42055 Saint-Etienne, France; F-CRIN INNOVTE network, Saint-Etienne, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1537-1891(21)00055-010.1016/j.vph.2021.106883
?:hasPublicationType
?:journal
  • Vascular pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34091065
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.352
?:rankingScore_hIndex
  • 83
is ?:relation_isRelatedTo_publication of
?:title
  • Thromboprophylaxis strategies to improve the prognosis of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all